1. Home
  2. ZLAB vs SXI Comparison

ZLAB vs SXI Comparison

Compare ZLAB & SXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • SXI
  • Stock Information
  • Founded
  • ZLAB 2013
  • SXI 1955
  • Country
  • ZLAB China
  • SXI United States
  • Employees
  • ZLAB N/A
  • SXI N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • SXI Industrial Machinery/Components
  • Sector
  • ZLAB Health Care
  • SXI Industrials
  • Exchange
  • ZLAB Nasdaq
  • SXI Nasdaq
  • Market Cap
  • ZLAB 3.4B
  • SXI 2.4B
  • IPO Year
  • ZLAB 2017
  • SXI N/A
  • Fundamental
  • Price
  • ZLAB $32.58
  • SXI $204.75
  • Analyst Decision
  • ZLAB Buy
  • SXI Strong Buy
  • Analyst Count
  • ZLAB 6
  • SXI 4
  • Target Price
  • ZLAB $57.22
  • SXI $223.50
  • AVG Volume (30 Days)
  • ZLAB 819.9K
  • SXI 86.0K
  • Earning Date
  • ZLAB 11-11-2025
  • SXI 10-28-2025
  • Dividend Yield
  • ZLAB N/A
  • SXI 0.61%
  • EPS Growth
  • ZLAB N/A
  • SXI N/A
  • EPS
  • ZLAB N/A
  • SXI 4.64
  • Revenue
  • ZLAB $427,799,000.00
  • SXI $790,107,000.00
  • Revenue This Year
  • ZLAB $42.62
  • SXI $14.61
  • Revenue Next Year
  • ZLAB $55.12
  • SXI $7.59
  • P/E Ratio
  • ZLAB N/A
  • SXI $45.23
  • Revenue Growth
  • ZLAB 32.56
  • SXI 9.64
  • 52 Week Low
  • ZLAB $20.17
  • SXI $128.85
  • 52 Week High
  • ZLAB $44.34
  • SXI $212.66
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 48.51
  • SXI 54.14
  • Support Level
  • ZLAB $31.68
  • SXI $197.66
  • Resistance Level
  • ZLAB $33.06
  • SXI $209.36
  • Average True Range (ATR)
  • ZLAB 1.34
  • SXI 5.50
  • MACD
  • ZLAB 0.21
  • SXI -1.17
  • Stochastic Oscillator
  • ZLAB 80.97
  • SXI 52.26

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About SXI Standex International Corporation

Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. The company has five reportable segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. The maximum revenue is generated from its Electronics segment, which is a component and value-added services provider of both sensing and switching technologies, as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging, among others. Geographically, it derives key revenue from the United States and the rest from the Asia Pacific, Europe, the Middle East, and Africa (EMEA), as well as other regions.

Share on Social Networks: